Delivery Order SPE2DB20D3103-SPE2DB24FP7A4
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
The federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The $11,566.64 firm fixed-price contract has a completion date of September 29, 2023 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,646.17 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 7, 2022, with a completion date of July 8, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,629.12 firm fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of the pharmaceutical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $18,675.71 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has an ultimate completion date of June 4, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order under contract SPE2DB20D3103/SPE2DB24FL6U2, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,607.64 firm fixed-price contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of November 29, 2023 and is not associated with a set-aside designation,...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,090.78, is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen Drug...
This federal contract award is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML pharmaceuticals to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,980.49, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and has an ultimate completion date of October 25, 2023. This award is not a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of pharmaceutical products, specifically REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, to the Defense Logistics Agency (DLA). The award, valued at $22,500.66, was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The federal contract award is for the delivery of Rebif Rebidose 44 mcg/0.5 ml medication, with a ceiling value of $4,103.33. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...